EZH2 and cancer: Moreover, PRC2 loss induces a genome-wide redistribution of the H3K27Ac mark and the activation of poised enhancers.62 Therefore, similar to EZH2, SUZ12 can act as pro-oncogenic or tumor suppressor depending on the cancer type.